Latest therapeutics News

Researchers shed light on how fetal alcohol exposure increases risk of development disorders
New partnership between BiomeBank and Hudson Institute
Microbiome medicine accelerated by new partnership between BiomeBank and Hudson Institute
Constant tinnitus is linked to altered brain activity
Dementia-linked protein map yields potential for treatments
New antimicrobial therapeutics to fight superbugs
PFIZER: TGA Approves Pfizer’s Novel Covid Oral Treatment in Australia
Statement on tenth meeting of International Health Regulations Emergency Committee regarding coronavirus disease pandemic
Development of fatty liver disease under healthy diet
WHO recommends two new drugs to treat Covid
New $23.3M Melbourne hub significant boost to diabetes research
Public’s view on using graphene to treat cancer sought
AstraZeneca and Scorpion Therapeutics enter agreement to discover, develop and commercialise novel cancer treatments against
$25.6 million investment to turbocharge Australian health projects
Federal grants to fund liver cancer, tissue repair and skin disease projects
Proposed rescheduling of medications – oral meloxicam and injectable lidocaine – submissions due
Moderna to build mRNA vaccine manufacturing facility in Australia
Bacteria biochemistry controlled with insoluble material
Common osteoporosis medication boosts immune response in lun
Seventh meeting of Multilateral Leaders Task Force on Covid Vaccines, Therapeutics and Diagnostics
AHPPC statement on Omicron public health implications and response options
Medical Research Future Fund support for clincial trials of mRNA-based vaccines and therapeutics
Researchers working on injection-free cell therapy for diabetes
QIMR Berghofer attracts support for potential multiple sclerosis treatment
Significant investments in data and digital capability to drive transformation of health and disability system
TaBriX, University and TB Alliance to develop drug-resistant tuberculosis treatments
Victoria to become home of mRNA vaccine manufacturing
Top 3 Covid vaccine questions – Boosters, assessing Omicron severity, and anxiety around holiday period
New strategy for treating cancer recognised with Victoria Prize
Victoria To Become Home Of mRNA Vaccine Manufacturing
Tumors differ depending on age of cancer patients
Targeting brain’s immune cells may block Alzheimer’s
WHO recommends against use of convalescent plasma to treat Covid
NZ secures new Pfizer Covid medicine
Australian Cancer Research Foundation awards $2.6M to establish International Centre for Cancer Glycomics
THC in blood and saliva are poor measures of cannabis impairment
QIMR Berghofer signs licensing, research and manufacturing deal for new cellular immunotherapy with US company Cellevolve Bio
Major gift helps launch Canine Health Center
CSL Joins StartX Community
Investment market update – Omicron
Victoria produces Australia’s first mRNA Covid vaccine candidate
Victoria Makes Australia’s First mRNA Vaccine Candidate
Radiometals and Radiohalogens: Potential New Combination for Cancer Treatment
Classification of Omicron: SARS-CoV-2 Variant of Concern
Centenary Institute receives $1.8m in funding for cardiovascular research
WHO and MPP announce first transparent, global, non-exclusive licence for Covid technology
Backing Victorian Women In mRNA And Medical Research
Making more effective and efficient RNA therapeutics